According to SEC Form 4 filings between October 25 to December 4, 2017, insiders at Celgene Corp. (NASDAQ:CELG), one of the top five constituents of the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), bought a total of 84,870 shares at prices between $31.21 per share and $98.17 per share in 4 transactions and sold 1,088 shares at $98.17 per share in one transaction, as shares of Celgene plunged about 35% in less than a month from its all-time high at $147.17 per share. Insiders might have thought that Wall Street was overreacting to the company's negative news announcements.
Sanofi S.A. (NYSE:SNY) said in a SEC Form 4 filing on September 25, 2017 that it purchased 166,413 common shares of Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) through its subsidiary Sanofi-Aventis Amerique du Nord from September 23 through September 24, 2017, at prices ranging from $467.78 per share to $488.82 per share. Sanofi now owns about 23.81 million outstanding shares, or a 20.35% stake in Regeneron. Sanofi might have thought that Regeneron shares were undervalued after it plunged over 20% from its June high of $543.55 per share. In January this year, Sanofi bought 87,298 common shares of Regeneron at prices ranging from $361.76 per share to $379.80 per share, after the stock sold-off almost 25%.
Top 5 Undervalued Stocks To Own For 2018: United Natural Foods, Inc.(UNFI)
Advisors' Opinion:- [By Stephan Byrd]
Algert Global LLC bought a new stake in shares of United Natural Foods (NASDAQ:UNFI) during the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 26,469 shares of the company’s stock, valued at approximately $1,137,000.
Top 5 Undervalued Stocks To Own For 2018: Astronics Corporation(ATRO)
Advisors' Opinion:- [By Joseph Griffin]
Astronics (NASDAQ: ATRO) and TransDigm Group (NYSE:TDG) are both aerospace companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.
- [By Ethan Ryder]
Astronics (NASDAQ: ATRO) and Ducommun (NYSE:DCO) are both small-cap aerospace companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations.
Top 5 Undervalued Stocks To Own For 2018: ePlus Inc.(PLUS)
Advisors' Opinion:- [By Lisa Levin]
Companies Reporting After The Bell Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion. Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million. Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion. Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million. Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million. Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million. Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million. Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million. DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion. 8x8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million. Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million. ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion. Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion. Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million. Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million. Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue - [By Ethan Ryder]
Tech Data (NASDAQ: TECD) and ePlus (NASDAQ:PLUS) are both retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.
Top 5 Undervalued Stocks To Own For 2018: Amgen Inc.(AMGN)
Advisors' Opinion:- [By ]
For example, if you buy 100 shares of the�Nasdaq�100�ETF�(NYSE: QQQ), you're theoretically buying 11.9 shares of Apple (NASDAQ: AAPL)... 7.7 shares of Facebook (NASDAQ: FB)... 1.8 shares of�Amgen�(NASDAQ: AMGN)... 2.6 shares of Comcast (NASDAQ: CMCSA)... and even smaller amounts of about 95 different companies.
- [By Jon C. Ogg]
In September of 2016, Amgen Inc. (NASDAQ: AMGN) announced that the FDA had approved its Amjevita as a biosimilar to Humira for multiple inflammatory diseases that included RA and several other related inflammatory diseases.
- [By Keith Speights]
Amgen (NASDAQ:AMGN) has been the hands-down winner over Celgene (NASDAQ:CELG) in terms of stock performance over the last year. It's the same story for revenue generated. Celgene beat Amgen in earnings, but only because of a technicality: Amgen incurred a big one-time tax hit in 2017.
- [By Todd Campbell]
One of these two drugs is Amgen's (NASDAQ:AMGN) Repatha, and the other is Praluent, which was co-developed by Sanofi SA (NYSE:SNY) and Regeneron Pharmaceuticals (NASDAQ:REGN). Both drugs launched to billion-dollar blockbuster expectations, but because they're complex biologics that are expensive to make, they cost about $14,000 per year. Their high cost, plus the fact that they're injected rather than taken orally, may make them best suited for patients with stubbornly high cholesterol who are at the greatest risk of heart disease.
Top 5 Undervalued Stocks To Own For 2018: Wausau Paper Corp.(WPP)
Advisors' Opinion:- [By ]
Embattled WPP Group (WPP) CEO Martin Sorrell, no stranger to business news channels and fat annual compensation checks, has quit as CEO. Below is a statement from Sorrell obtained by TheStreet.
- [By Lisa Levin] Gainers Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares rose 29.5 percent to $2.15 in pre-market trading after reporting pre-clinical data demonstrating potential of Prexigebersen presented at the annual American Association for Cancer Research meeting in Chicago. Sientra, Inc. (NASDAQ: SIEN) rose 16.7 percent to $12.90 in pre-market trading following the announcement of FDA approval for PMA supplement. Aqua Metals, Inc. (NASDAQ: AQMS) rose 13.5 percent to $2.95 in pre-market trading after climbing 14.04 percent on Wednesday. Harmony Gold Mining Company Limited (NYSE: HMY) rose 5.6 percent to $2.09 in pre-market trading. Alcoa Corporation (NYSE: AA) shares rose 5 percent to $62.32 in pre-market trading after the company reported better-than-expected earnings for its first quarter and raised its FY18 adjusted EBITDA outlook. Gold Fields Limited (ADR) (NYSE: GFI) shares rose 4.9 percent to $4.11 in pre-market trading after gaining 1.03 percent on Wednesday. ABB Ltd (NYSE: ABB) shares rose 4.3 percent to $24.47 in pre-market trading after reporting Q1 results. WPP plc (NYSE: WPP) rose 4.2 percent to $82.99 in pre-market trading. American Express Company (NYSE: AXP) rose 4 percent to $98.95 in pre-market trading after the company reported stronger-than-expected profit for its first quarter. HSBC Holdings plc (NYSE: HSEA) rose 3.4 percent to $27.30 in pre-market trading. Shire plc (NASDAQ: SHPG) rose 3.4 percent to $167.95 in pre-market trading. Takada offered to buy Shire at £46.50 per share, Reuters reported. Vipshop Holdings Limited (NYSE: VIPS) rose 3.1 percent to $16.43 in pre-market trading. iRobot Corporation (NASDAQ: IRBT) shares rose 3 percent to $63.66 in the pre-market trading session.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
No comments:
Post a Comment